Experimental chikungunya vaccine shows promise in human trial

WASHINGTON (Reuters) - An experimental vaccine being developed by U.S. government scientists to prevent the painful mosquito-borne viral disease chikungunya has shown promise in its first human trials but remains years away from approval for widespread use.
Source: Reuters: Health - Category: Consumer Health News Tags: healthNews Source Type: news